Psychiatric comorbidity in patients with vitiligo and chronic urticaria;Vitiligo ve kronik ütiker hastahlarinda psikiyatrik eş tani

Anadolu Psikiyatri Dergisi

Volumn 8, Issue 1, 2007, Pages 30-36

  Sukan, Meltem ^a   Maner, Fulya ^b  

^a Mardin Park Hastanesi   (Turkey)

^b Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi   (Turkey)

Author keywords

Chronic urticaria; Dysthymic disorder; Generalized anxiety disorder; Vitiligo

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHRONIC URTICARIA; CLINICAL FEATURE; COMORBIDITY; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTHYMIA; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; STATISTICAL ANALYSIS; TURKEY (REPUBLIC); VITILIGO;

EID: 33947113414     PISSN: 13026631     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Moschella SL, Hurley HJ. Dermatology. Third edition, vol. 2, Philadelphia, WB. Saunders, 1992, p. 1442-1474.
2. Arnold HL, Odom RB, James WD. Diseases of the skin. Eight ed., Philadelphia, W.B. Saunders, 1990, p. 194-222.
3. Ginsburg IH. The psychosocial impact of skin disease. An overview. Dermatol Clin 1996; 14:473-484.
4. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol 1997; 137:246-250.
5. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes 2003; 1:58.
6. Yüzüak Türe T. Kronik İdiopatik Ürtikerli Hastalarda Otolog Serum Deri Testi Pozitifliǧi ve Tiroid Otoantikorlari ile İlişkisi. Yayimlanmamiş Uzmanlik Tezi, İstanbul, Haseki Eǧitim ve Araştirma Hastanesi, Dermatoloji Bölümü, 2004.
7. Hashiro M, Okumura M. Anxiety, depression, psychosomatic symptoms and autonomic nervous function in patients with chronic urticaria. J Dermatol Sci 1994; 8:129-135.
8. Gilchrest BA. Pruritus: pathogenesis, therapy, and significance in systemic disease states. Arch Intern Med 1982; 142:101-105.
9. Koblenzer CS. Psychosomatic concepts in dermatology. A dermatologist-psychoanalyst's viewpoint. Arch Dermatol 1983; 119:501-512.
10. Topal IO, Mercan S, Altunay IK. Kronik ürtikerli hastalarda kişilik bozukluklari, anksiyete ve depresyon. 40. Ulusal Psikiyatri Kongresi Bildiri Özet Kitabi, Kuşadasi, 2004, s.610-612.
11. Hein UR, Henz BT, Haustein UF. Zur Beziehung zwischen chronischer urtikaria und depression/Somatisierungsstörung. Hautarzt 1996; 47:20-23.
12. Sheehan-Dare RA, Henderson MJ, Cotterill JA. Anxiety and depression in patients with chronic urticaria and generalized pruritus. Br J Dermatol 1990; 123:769-774.
13. Preston K. Depression and skin diseases. Med J 1969; 1:326-329.
14. Lyketsos GC, Stratigos J, Tawil G. Hostile personality characteristics, dysthymic states and neurotic symptoms in urticaria, psoriasis and alopecia. Psychother Psychosom 1985; 44:122-131.
15. Taner E, Burhanoǧlu S, Coşar B, Önder M. Behçet Hastaliǧi olan hastalarda anksiyete ve depresyonun psöriasis hastalartyla karşilaştirilmasi. Türkiye'de Psikiyatri 2006; 8:27-29.
16. Yaluǧ I, Aydoǧan G, Savrun M. Konversiyon bozukluǧu ve psoriasiste depresyon ve eǧitim düzeyinin primer ve sekonder aleksitimi üzerine etkisinin araştirilmasi. Düşünen Adam 2003; 16:80-86.
17. Özgüven HD, Kundakçi N, Boyvat A. Psoriasis hastalarinda ikincil sosyal anksiyete. Türk Psikiyatri Dergisi 2000; 11:121-126.
18. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version, 1997.
19. Özkürkçügil A, Aydemir Ö, Yildiz M, Esen Danaci A, Köroǧlu E. DSM-IV eksen I bozukluklari için yapilandirilmiş klinik görüşmenin Türkşeye uyarlanmasi ve güvenilirlik çalişmasi. Ilaç ve Tedavi Dergisi 1999; 12:233-236.
20. Mattoo SK, Handa S, Kaur I. Psychiatric morbidity in vitiligo and psoriasis: a comparative study from India. J Dermatol 2001; 28:424-432.
21. Mattoo SK, Handa S, Kaur I. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol 2002; 16:573-578.
22. Porter J, Beuf AH, Lerner A, Nordlund J. Response to cosmetic disfigurement: patients with vitiligo. Cutis 1987; 39:493-494.
23. Weiss MG, Doongaji DR, Siddhartha S. The Explanatory Model Interview Catalogue (EMIC). Contribution to cross-cultural research methods from a study of leprosy and mental health. Br J Psychiatry 1992; 160:819-830.
24. Attah Johnson FY, Mostaghimi H. Co-morbidity between dermatologic diseases and psychiatric disorders in Papua New Guinea. Int J Dermatol 1995; 34:244-248.
25. Bagadia VN, Ayyar KS, Pradhan PV. Life stress in dermatology outpatients. Arch Ind Psychiatry 1998; 4:47-49.
26. Pulimood S, Rajagopalan B, Rajagopalan M. Psychiatric morbidity among dermatology inpatients. Natl Med J India 1996; 9:208-210.
27. Picardi A, Abeni D, Melchi CF. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
28. Sharma N, Koranne RV, Singh RK. Psychiatric morbidity in psoriasis and vitiligo: a comparative study. J Dermatol 2001; 28:419-423.
29. Hughes JE, Barraclough BM, Hamblin LG. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983; 143:51-54.
30. Farber EM, Nall ML. The natural history of psoriasis in 5600 patients. Dermatologica 1974; 148:1-18.
31. Picardi A, Pasquini P, Cattaruzza MS. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom 2003; 72:150-158.
32. Fritzsche K, Ott J, Zschocke I. Psychosomatic liaison service in dermatology. Dermatology 2001; 203:27-31.